0.3850EUR+1.18%Mkt Cap: —P/E: —1d ago
Nicox S.A., together with its subsidiaries, operates as an ophthalmology company in France and internationally. It develops solutions to preserving vision and improve eye health. The company's lead product candidate is N…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value32.81M $
Revenue (TTM)18.23M $
Gross Profit7.11M $
Net Income (TTM)-2.62M $
Revenue/Share0.2272 USD
Last Price0.3850 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees10
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA4.55
EV/Revenue1.80
P/S—
P/B5.66
EPS (TTM)-1.17
EPS (Forward)—
52W Range
0.3805100% of range0.3850
52W High0.3850 EUR
52W Low0.3805 EUR
Profitability
Gross Margin38.99%
Oper. Margin77.28%
EBITDA Margin39.58%
Profit Margin-14.39%
ROE-51.16%
ROA23.81%
Growth
Revenue Growth751.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-4.07M $
Net Debt/EBITDA-0.56
Balance Sheet
Debt/Equity6.71
Current Ratio4.17
Quick Ratio3.00
Book Value/Sh0.0680 EUR
Cash/Share0.0470 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.2:1
Split DateDec 3, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.29.59M
Float85.07M
Insiders5.14%
Institutions1.60%
Technical
SMA 500.4110 (-6.3%)
SMA 2000.4858 (-20.8%)
Beta0.51
S&P 52W Chg18.16%
Avg Vol (30d)17.17K
Avg Vol (10d)22
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—